The Cost of NOT Testing
COVID-19 Testing at Workplace: It’s Not a Matter of Personal Privacy. Read More>>
Early detection saves lives. And businesses.
InOut Labs’ employee screening process helps detect both symptomatic and asymptomatic individuals.
COVID-19 symptoms appear 2-14 days after exposure to the virus. Temperature checks alone are a start, but a fever may not show up right away. And by the time an individual has a COVID-related fever, s/he has been infected for as long as 2 weeks.
COVID-19 Testing Options for the Workplace
PCR (Molecular) Test – For Active Infections
Molecular tests (also known as PCR tests) detect genetic material from the virus. The PCR viral test is the current gold standard for detecting active infection.
- Results in 2-3 Days
- Painless Nasal Swab (Self administered. NOT the brain probing nasal pharyngeal swab)
- Detects active infection in pre-symptomatic and symptomatic period
Important Information: These tests are not yet approved or cleared by the FDA. No currently available COVID-19 tests are FDA approved or cleared.
When there are no FDA-approved or cleared tests available, and other criteria are met, the FDA can make tests available under an emergency access mechanism called an Emergency Use Authorization (EUA).
The EUA for these tests is supported by the Secretary of Health and Human Service’s (HHS’s) declaration that circumstances exist to justify the emergency use of in vitro diagnostics for the detection and/or diagnosis of the virus that causes COVID-19.
This EUA will remain in effect (meaning this test can be used) for the duration of the COVID-19 declaration justifying emergency of IVDs, unless it is terminated or revoked by FDA (after which the test may no longer be used).
FAQs
For Information
"*" indicates required fields